Primary Job Title Associate Professor Primary Organization 
Tufts University
Location Boston, Massachusetts, United States Regions Greater Boston Area, East Coast, New England Gender Male
LinkedIn View on LinkedIn
Rajendra Kumar-Singh is a tenured Professor in the Department of Developmental, Molecular and Chemical Biology at Tufts University School of Medicine. He is also the Director of the Program in Genetics at Tufts University and a Co Founder and Vice President of Hemera Biosciences Inc. – a start up company focused on the development of a gene
therapy for the dry form of age related macular degeneration- the most common cause of blindness in the elderly. Rajendra obtained his PhD at the University of Dublin, Ireland in the field of ocular genetics, after which he completed postdoctoral training at the University of Michigan in the field of gene therapy. Rajendra then held faculty positions at the University of California, Los Angeles and the University of Utah prior to joining Tufts University. His research is funded by the Department of Defense, National Institutes of Health and several private foundations. Rajendra’s research has led to the development of an inhibitor of the membrane attack complex (MAC) that is thought to play a role in the pathogenesis of dry AMD and other complement associated disorders.
